<DOC>
	<DOCNO>NCT01943084</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial investigate bioequivalence ( expect biological equivalence two pharmaceutical drug product identical active ingredient ) Norditropin速 ( somatropin ) versus Genotropin速 ( somatropin ) healthy adult subject .</brief_summary>
	<brief_title>A Trial Investigate Bioequivalence Norditropin速 ( Somatropin ) Versus Genotropin速 ( Somatropin ) Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Healthy subject trial entry previous exposure recombinant human growth hormone IGFI ( insulinlike growth factorI ) Body mass index ( BMI ) 18.027.0 kg/m^2 ( inclusive ) Considered generally healthy upon completion medical history , physical examination , vital sign , screen laboratory result , electrocardiogram ( ECG ) , judge investigator The receipt investigational medicinal product within 1 month prior trial Current previous treatment growth hormone IGFI Female childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method ( adequate contraceptive measure require local law practice ) duration trial Known presence history malignancy Diabetes mellitus Use systemic corticosteroid Use anabolic steroid History drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>